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Abstract: A range of iridium(I) complexes of the type [Ir(cod)(NHC)PPh3)]X are reported, where the
N-heterocyclic carbene (NHC) is derived from the naturally-occurring imidaozlium salt, Lepidiline
A (1,3-dibenzyl-4,5-dimethylimidazolium chloride). A range of complexes were prepared, with a
number of NHC ligands and counter-ions, and various steric and electronic parameters of these
complexes were evaluated. The activity of the [Ir(cod)(NHC)PPh3)]X complexes in hydrogen isotope
exchange reactions was then studied, and compared to established iridium(I) complexes.
Keywords: iridium; N-heterocyclic carbene; hydrogen isotope exchange; deuterium
1. Introduction
Isotopically labelled compounds are of importance in a range of scientific disciplines. In particular,
the isotopes of hydrogen, deuterium, and tritium find application in several key areas. Within the
physical sciences, deuterated compounds are routinely used in the elucidation of reaction
mechanisms [1]. In the life sciences, deuterated and tritiated compounds are used to determine
the pharmacokinetic properties of bioactive molecules [2–4]. More recently, active pharmaceutical
ingredients themselves have begun to feature deuterium, exploiting the effect of relative C-H/C-D
bond strengths to deliver drug molecules with improved metabolic profiles [5,6].
Amongst the synthetic methods available for incorporation of deuterium or tritium into a molecule,
hydrogen isotope exchange (HIE) stands out due to its simplicity and generality [7–9]. A particularly
powerful variant of this process is directed HIE, whereby a Lewis basic group within the molecule
directs a metal catalyst to an adjacent site, and a subsequent C-H activation results in a metallocyclic
intermediate which facilitates HIE at this adjacent position (Scheme 1).
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Iridium(I) complexes are amongst the most effective metal catalysts for directed HIE [10] and,
in recent years, we have introduced a suite of highly active Ir(I) catalysts bearing a combination of
bulky phosphine and N-heterocyclic carbene ligands (Figure 1). These catalysts are compatible with a
broad variety of directing groups, enabling HIE on a wide range of substrates [11–18].
Catalysts 2020, 10, x FOR PEER REVIEW 2 of 11 
 
Iridium(I) complexes are amongst the most effective metal catalysts for directed HIE [10] and, 
in recent years, we have introduced a suite of highly active Ir(I) catalysts bearing a combination of 
bulky phosphine and N-heterocyclic carbene ligands (Figure 1). These catalysts are compatible with 
a broad variety of directing groups, enabling HIE on a wide range of substrates [11–18]. 
 
Figure 1. Iridium(I) N-heterocyclic carbene (NHC)/phosphine complexes for directed hydrogen 
isotope exchange. 
These benchmark complexes 1–2 feature three distinct phosphine ligands. However, our early 
studies [11,12], which focused on identifying the most effective catalyst system, evaluated a broader 
range of phosphines based on their steric and electronic properties. In contrast, although we have 
optimised the NHC ligand for some specific HIE use cases [19,20], there remains scope for a more 
systematic study of the steric and electronic parameters of this ligand component. The natural 
product Lepidiline A 3·HCl is an imidazolium chloride salt, featuring two N-benzyl substituents, and 
methyl groups at the heterocycle’s 4- and 5-positions [21] (Figure 2). We envisaged that this naturally-
occurring imidazolium salt could serve as a vehicle to begin to explore the effect of steric and 
electronic changes in the NHC on the activity of our Ir(I) NHC/phosphine catalysts [22]. 
 
Figure 2. Naturally-occurring imidazolium salt Lepidiline A 3·HCl. 
Herein we report a study of the complexes 1a, 6a and 7, of the type [Ir(cod)(NHC)PPh3)]PF6 (cod 
= 1,5-cyclooctadiene), where the NHC ligand is IMes 4, IBn 5, or IBnMe 3, derived from Lepidiline A 
3·HCl (Figure 3). These complexes are then used to explore the effect of steric and electronic variance 
within the NHC through comparison of (a) N-benzyl vs. N-mesityl substituents; and (b) 4,5-H2 vs. 
4,5-Me2 substitution, on the reactivity in HIE processes. The effect of the counter on the activity of the 
IBnMe complexes is also investigated. 
 
Figure 3. Iridium(I) complexes with varying NHC ligands to probe their steric and electronic 
influence. 
2. Results and Discussion 
To initiate our studies, we set out to prepare quantities of the desired [Ir(cod)(NHC)PPh3)]PF6 
complexes 1a, 6a and 7. Complex 1a was prepared by a modification of previously reported 
conditions [11,23]. The IBn-containing complex 7 was prepared [23] by using an analogous procedure 
from the previously reported complex [Ir(cod)(IBn)Cl] [24]. Lastly, the imidazolium chloride salt 
3·HCl, representing the natural product Lepidiline A, was targeted to deliver complex 6a. 
 
Figure 1. Iridium(I) N-heterocyclic carbene (NHC)/phosphine complexes for directed hydrogen
isotope exchange.
These bench ark co plexes 1–2 feature three distinct phosphine ligands. o ever, our early
studies [11,12], hich focused on identifying the ost effective catalyst syste , evaluated a broader
range of phosphines based on their steric and electronic properties. In contrast, although e have
opti ised the C ligand for so e specific IE use cases [19,20], there re ains scope for a ore
syste atic study of the steric and electronic parameters of this ligand component. The natural product
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groups at the heterocycle’s 4- and 5-positions [21] (Figure 2). We envisaged that this naturally-occurring
imidazolium salt could serve as a vehicle to begin to explore the effect of steric and electronic changes
in the NHC on the activity of our Ir(I) NHC/phosphine catalysts [22].
Catalysts 2020, 10, x FOR PEER REVIEW 2 of 11 
 
Iridium(I) complexes are amongst the most effective metal catalysts for directed HIE [10] and, 
in recent years, we have introduced a suite of highly active Ir(I) catalysts bearing a combination of 
bulky phosphine and N-heterocyclic carbene ligands (Figure 1). These catalysts are compatible with 
a broad variety of directing groups, enabling HIE on a wide range of substrates [11–18]. 
 
Figure 1. Iridiu (I) -heterocyclic carbene ( C)/phosphine co plexes for directed hydrogen 
isotope exchange. 
These benchmark complexes 1–2 feature three distinct phosphine ligands. However, our early 
studies [11,12], which focused on identifying the most effective catalyst system, evaluated a broader 
range of phosphines based on their steric and electronic properties. In contrast, although we have 
optimised the NHC ligand for some specific HIE use cases [19,20], there remains scope for a more 
systematic study of the steric and electronic parameters of this ligand component. The natural 
product Lepidiline A 3·HCl is an imidazolium chloride salt, featuring two N-benzyl substituents, and 
methyl groups at the heterocycle’s 4- and 5-positions [21] (Figure 2). We envisaged that this naturally-
occurring imidazolium salt could serve as a vehicle to begin to explore the effect of steric and 
electronic changes in the NHC on the activity of our Ir(I) NHC/phosphine catalysts [22]. 
 
Figure 2. Naturally-occurring imidazolium salt Lepidiline A 3·HCl. 
Herein we report a study of the complexes 1a, 6a and 7, of the type [Ir(cod)(NHC)PPh3)]PF6 (cod 
= 1,5-cyclooctadiene), where the NHC ligand is IMes 4, IBn 5, or IBnMe 3, derived from Lepidiline A 
3·HCl (Figure 3). These complexes are then used to explore the effect of steric and electronic variance 
within the NHC through comparison of (a) N-benzyl vs. N-mesityl substituents; and (b) 4,5-H2 vs. 
4,5-Me2 substitution, on the reactivity in HIE processes. The effect of the counter on the activity of the 
IBnMe complexes is also investigated. 
 
Figure 3. Iridium(I) complexes with varying NHC ligands to probe their steric and electronic 
influence. 
2. Results and Discussion 
To initiate our studies, we set out to prepare quantities of the desired [Ir(cod)(NHC)PPh3)]PF6 
complexes 1a, 6a and 7. Complex 1a was prepared by a modification of previously reported 
conditions [11,23]. The IBn-containing complex 7 was prepared [23] by using an analogous procedure 
from the previously reported complex [Ir(cod)(IBn)Cl] [24]. Lastly, the imidazolium chloride salt 
3·HCl, representing the natural product Lepidiline A, was targeted to deliver complex 6a. 
 
Fig re 2. at rally-occ rri g i i azoli salt e i ili e 3· l.
i t a study of the complexes 1a, 6a and 7, of the type [Ir(cod)(NHC)PPh3)]PF6
(cod = 1,5-cyclooctadiene), wher the NHC ligand is IMes 4, IBn 5, or IBnMe 3, derived from Lepidiline
A 3·HCl (Figure 3). Th se complexes are then used to explore the effect of steric
it i t thro co aris of (a) -benz l vs. 2
, - e2 . ff i it f
I l i l i .
Catalysts 2020, 10, x FOR PEER REVIEW 2 of 11 
 
Iridium(I) complexes are amongst th  most effective metal t l ts for directed HIE [10] and, 
in recent years, we have intr duced  suit  of highly active Ir(I) catalysts bearing a combination of 
ulky phosphine and N-heter cyclic carbe e liga ds (Figure 1). These catalysts are compatible with 
a broad variety of directing groups, enabling HIE on a wide range of substrates [11–18]. 
 
Figure 1. Iridium(I) N-heterocyclic carbene (NHC)/phosphine complexes for directed hydrogen 
isotope exchange. 
These benchmark complexes 1–2 feature three distinct phosphine ligands. However, our early 
studies [11,12], which focused on identifying the most effective catalyst system, evaluated a broader 
range of phosphines base  on their steric and electronic properties. In contrast, although we have 
optimised the NHC ligand for some specific HIE use cases [19,20], there remains scope for a more 
systematic study of the steric and electronic parameters of this ligand component. The natural 
product Lepidiline A 3·HCl is an imidazolium chloride salt, featuring two N-benzyl substituents, and 
methyl groups at the heterocycle’s 4- and 5-positions [21] (Figure 2). We envisaged that this naturally-
occurring imidazolium salt could serve as a vehicle to begin t  explore the effect of steric and 
electronic changes in the NHC on the activity of our Ir(I) NHC/phosphine catalysts [22]. 
 
Figure 2. Naturally-occurring imidazolium salt Lepidiline A 3·HCl. 
Herein we report a study of the complexes 1a, 6a and 7, of the typ  [Ir(cod)(NHC)PPh3)]PF6 (cod 
= 1,5-cyclooctadiene), where the NHC ligand is IMes 4, IBn 5, or IBnMe 3, derived from Lepidiline A 
3·HCl (Figure 3). These complexes are then used to explore the effect of steric a d electronic variance 
within the NHC through comparison of (a) N-benzyl vs. N-mesityl substituents; and (b) 4,5-H2 vs. 
4,5- e2 substitution, on the reactivity in HIE processes. The effect of the counter on the activity of the 
IBnMe complexes is also investigated. 
 
Fig re 3. Iridium(I) complexes with varying NHC ligands to probe their steric and electronic 
influence. 
2. Results and Discussion 
To initiate our studies, we set out to pre are quantities of the desired [Ir(cod)(NHC)PPh3)]PF6 
c mplexes 1a, 6a and 7. Complex 1a was prepared by a modification of previously reported 
conditions [11,23]. The IBn-containing complex 7 was prepared [23] by using an analogous procedure 
from the previously reported complex [Ir(cod)(IBn)Cl] [24]. Lastly, the imidazolium chloride salt 
3·HCl, representing the natural product Lepidiline A, was targeted to deliver complex 6a. 
 
Fig re 3. Iridium(I) complexes with varying NHC ligands to probe their steric and electronic influence.
2. Results and iscussion
To initiate our studies, e set out to prepare quantities of the desired [Ir(cod)(NHC)PPh3)]PF6
co plexes 1a, 6a and 7. Co plex 1a as prepared by a odificat on of previously reported
onditions [11,23]. The IBn-containing co plex 7 s prepared [23] by using an analogous procedure
fr the previously reported complex [Ir(cod)(IBn)Cl] [24]. Lastly, the imidazolium chloride salt 3·HCl,
representing the natural product Le idiline A, was targeted to deliver complex 6a.
Catalysts 2020, 10, 161 3 of 11
2.1. Synthesis of Lepidiline A
Surprisingly, to our knowledge, no preparation of this naturally-occurring material has yet been
reported. Our synthetic route is summarised in Scheme 2. Chlorination of the commercially available
hydroxymethyl imidazolium salt 8 in neat thionyl chloride was easily achieved in excellent yield on a
multi-gram scale to deliver 9. Reduction and basification of 9 yielded the free 4,5-dimethylimidazole
10 with good levels of efficiency. Subsequently, double-alkylation of 10 under basic conditions could
be achieved using benzyl chloride to give Lepidiline A 3·HCl with good effectiveness, or with benzyl
bromide to give 3·HBr in excellent yield. Imidazolium bromide 3·HBr could then undergo salt
metathesis to very efficiently afford 3·HPF6 and 3·HBArF.
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2.2. Preparation of Iridium Complexes Based on Lepidiline A 3
With a range of imidazolium salt precursors in hand, formation of the corresponding
iridium complexes was investigated. Based on work by Wang and Lin [25], and Liu et al. [26],
the [(cod)Ir(NHC)Cl] complexes can be prepared via a transmetallation procedure from the
corresponding silver bis-carbene complex. Employing the bromide salt 3·HBr, mixing with silver(I)
oxide and sodium iodide in dichloromethane gave silver complex 11 in high yield (Scheme 3).
This intermediate could be taken forward into a transmetallation procedure with [(cod)IrCl]2 13 to
provide the desired chloro-carbene complex 12 in excellent yield following a short reaction time.
Alternatively, it was also found that isolation of 11 could be circumvented via direct addition of
[(cod)IrCl]2 13 following in situ formation of the silver complex 11, delivering 12 in a further improved
overall yield. With this high-yielding method in place, X-ray quality crystals of 12 were grown,
confirming the proposed structure (Figure 5).
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probability ellipsoids. H atoms and disorder in the orientation of one phenyl ring have been omitted
for clarity.
With quant ties of the NHC chlori e compl x 12 s cur d, treatment with triphenylphosphine,
followed by silver h xafluorophosphate, eliver d targ t NHC-phosphine complex 6a in a good 75%
yield (Tabl 1, entry 1). In order to probe the effects of varying the counter-ion in these novel complexes,
derivatives 6b–6d were also prepared in an analogous manner and with excellent isolated yields
(Table 1, entries 2−4).
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Table 1. Preparation of [(cod)Ir(IBnMe)PPh3]X complexes 6a–6d.
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Entry Complex X Yield
1 6a PF6 75
2 6b BF4 87
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e have previously shown that iridium NHC/phosphine complexes bearing a BArF (tetrakis
[3,5-bis(trifluoromethyl)phenyl]borate) counter-ion have a broader solvent applicability than the
corresponding PF6 complexes [13]. Based on this, BArF-containing complex 6e was prepared in a
one-pot procedure from [(cod)IrCl]2 13 in a good 82% yield (Scheme 4). Complexes 6a–6e were all
characterized by X-ray crystallography [23].
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l are often characterised by carbonylation of the complex, whereby t νCO stretching frequency
reports on the electron-donating nature of the other ligands on the metal [27]. Recent work on Ir(I)
dicarbonyl complexes has revealed that the configuration of the carbonyl ligands, though preferentially
cis, is dictated by the ligand size, with l rger combinations driving a trans dicarbonyl arrangement [28].
This structural fluidity limits the use of electronic param t rs derived from such complexes [28].
However, the synthesis and X-ra characterisation of t e c rbonlyated analogues f our NHC/phosphine
complexes could instead be us d t indicat a steric threshol —the ligand siz at which Ir(I) carbonyl
complexes switch fr m a cis- to a trans-configuration, and this could be correl ted with the well-known
steric parameter, p rcentage buried volume, %Vbur, [29] of the ligands.
Accordingly, we investigated the carbonylation of complexes 1a, 6a, and 7 (Scheme 5).
Direct exposure of complexes 6a and 7 t an atmosphere of CO resulted in complexes 14 and
15, where both the NHC/phosphine p ir and the two CO ligands are each cis-orientated, as shown by
t e X-ray crystal structures [23]. The c mbined ligand %Vbur values (Σ(%Vbur)) were similar for both
complexes, as determined by density functional theory (DFT) calculations (Table 2) [23]. As perhaps
expected, the enhanced bulk of the NHC ligand in 1a resulted in a complex, 16, with a trans-arrangement
of the NHC/P pair and of the two CO ligands, indicating the size and geometry of this co plex to be
quite distinct from the IBn and IBnMe analogues 14 and 15. Based on these parameters, there is little
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steric difference evident on moving from the IBn to the IBnMe ligand, with the latter appearing to be a
very slightly bulkier system, based on the %Vbur values.
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Table 2. Properties of Ir-carbonyl complexes 14–16.
Entry Complex N-Substituent R Yield %Vbur(PPh3) 2
%Vbur
(NHC) 2
Σ
(%Vbur)
θ (◦) 1
1 14 Bn H 49% 26.9 28.9 55.8 93.2
2 15 Bn Me 50% 27.0 29.2 56.2
89.4 3
92.6 3
3 16 Mes H 68% 27.9 32.6 60.5 160.0
1 θ represents the angle OC-Ir-CO. 2 Representative %Vbur values are calculated from DFT-optimized
[(NHC)(PPh3(Ir(H)2(DCM)2]+ complex cations. Full details are presented in the SI. 3 Carbonyl complex 15
crystallized with two different conformations.
Although these dicarbonyl complexes permitted only a steric, and not electronic, evaluation,
literature examples of Ir(I) chloro-carbonyl complexes have demonstrated that the combined influence
of various ligand partnerships on the metal’s pi-donating ability can be measured via IR spectroscopy,
based on the carbonyl stretching frequency, νCO [26,30]. Furthermore, the effect of the ligands on
the σ-donating nature of the complex can be measured by 1H nuclear magnetic resonance (NMR)
spectroscopic evaluation of the corresponding dihydride complexes [31]. The electronic characteristics of
the IMes, IBn, and IBnMe ligands in our complexes were thus explored by preparing the chloro-carbonyl
complexes, 17–19 (Table 3). Additionally, from the NHC/PPh3 complexes, in situ generation of the
dihydride complexes 20–22, in CD3CN [23], provided insight into the σ-donating properties (Table 3).
Based on both electronic parameters, the IBnMe/PPh3 combination was found to be slightly more
electron-rich than IBn/PPh3,, and more significantly less electron-rich than IMes/PPh3.
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2.4. Evaluation of Iridium Complex Catalytic Activity in HIE
We next chose to focus on the relationship between the IBn/PPh3 and IBnMe/PPh3 complex pair
in terms of catalyst activity in HIE reactions. The two precatalysts 6a and 7 were compared via
kinetic analysis of the simple reference labelling reaction with acetophenone 23 (Table 4). Catalyst 6a,
derived from Lepidiline A, was clearly faster reacting, displaying a pseudo first order rate constant,
kobs(6a) = 0.0224 s−1, versus kobs(7) = 0.0145 s−1 for IBn/PPh3 catalyst 7 [23].
Table 4. Evaluation of complexes 6a and 7 in a benchmark HIE reaction.
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Entry Complex NHC kobs
1 6a IBnMe .0224 s−1
2 7 IBn 0.0145 s−1
This result was supported by DFT modelling of the turnover-limiting [12] C-H activation step
(24→26, Scheme 6). Based on our electronic characterization of these complexes, the greater reactivity
of catalyst 6a over 7 can be rationalised on the basis of an increased pi-donating ability of the Ir centre,
and not on any appreciable steric difference between the two catalysts 6a and 7.
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substrate, itrobenzene 30, whereas th flagship IMes/PPh3 ystem 1a labels to ~95% D under
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Table 5. Evaluation of counter-ion effects in IBnMe/PPh3 complexes 6.
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3. Materials and Methods 
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4. Conclusions 
In summary, the first synthesis of the simple imidazolium-based natural product, Lepidiline A, 
3·HCl, has been reported, along with a range of other counter-ion derivatives. This has been followed 
by the development of novel HIE catalysts and the use of a silver-NHC transmetallation approach to 
HIE catalyst synthesis. Detailed and combined experimental/computational analysis of the resulting 
iridium complexes 6 and 7 has led to quantitative insight into the parameters responsible for observed 
differences in the resulting catalytic reactivity of 6a versus the less substituted analogue, 7, and 
existing flagship HIE catalyst, 1a. Overall, dimethyl substitution on the backbone of the novel NHC 
was found to impart an electronic influence with a minimal impact on the steric environment. The 
reactivity differences between the catalysts studied are now being exploited in labelling 
regioselectivity studies, which will be reported in due course. 
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3. Materials and Methods
See the Supplementary Information for details of all experimental and computational procedures,
as well as all crystallographic data.
4. Conclusions
In summary, the first synthesis of the simple imidazolium-based natural product, Lepidiline A,
3·HCl, has been reported, along with a range of other counter-ion derivatives. This has been followed
by the development of novel HIE catalysts and the use of a silver-NHC transmetallation approach to
HIE catalyst synthesis. Detailed and combined experimental/computational analysis of the resulting
iridium complexes 6 and 7 has led to quantitative insight into the parameters responsible for observed
differences in the resulting catalytic reactivity of 6a versus the less substituted analogue, 7, and existing
flagship HIE catalyst, 1a. Overall, dimethyl substitution on the backbone of the novel NHC was found
to impart an electronic influence with a minimal impact on the steric environment. The reactivity
differences between the catalysts studied are now being exploited in labelling regioselectivity studies,
which will be reported in due course.
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